Delivery Order SPE2DB20D3101-SPE2DB25FQZF9
Award Date
1/17/25
Potential Completion Date
2/10/25
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,859.50, is for the delivery of the drug Zoladex 10.8 mg Implant Syringe. The contract has a completion date of June 5, 2025 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating open competition. This award is part of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,648.75 firm fixed-price contract is for the supply of 4,568,124,865 units of the drug Zoladex 10.8 mg Implant Syringes. The contract has a performance period through May 22, 2025 and is not designated as a set-aside. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,789.25, is for the delivery of Zoladex 10.8 mg implant syringes, a medication used for the treatment of certain medical conditions. The contract is a firm fixed-price delivery order, with a performance period ending on May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award SPE2DB22D2206|SPE2DB24FJL31 was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Zoladex 10.8 mg implant syringes. The $5,263.74 firm fixed-price delivery order has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,565,606,804 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a firm fixed price ceiling value of $1,754.58 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded this delivery order contract without any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at up to $1,561.45, is for the delivery of the drug Zoladex 3.6 mg implants. It is a firm fixed-price Delivery Order contract with a completion date of July 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $21,932 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS medical devices. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,782.64 Firm Fixed Price Delivery Order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,263.74 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product related to healthcare. The contract has an ultimate completion date of November 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price and a ceiling value of $1,859.50. The contract is not set aside and will deliver ZOLADEX 10.8 MG IMPLANT SYRNS to the government. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...